The Practical Evidence of Antidiabetic Combination Therapy in Korea

NCT02231021 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

216

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: alogliptin
DRUG: Pioglitazone
DRUG: alogliptin + pioglitazone

Sponsor

Kun-Ho Yoon

Collaborators

[object Object]